Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis

Clin Cancer Res. 1996 Dec;2(12):1969-79.

Abstract

Interleukin 10 (IL-10) inhibits the production of a wide range of cytokines in various cell types. The purpose of this study was to determine whether the expression of the IL-10 gene can influence tumor growth and metastatic properties of human melanoma cells. The human melanoma cell line, A375P, which does not produce endogenous IL-10, was transfected with a hygromycin expression vector (control) or a vector containing full-length murine IL-10 cDNA. A375P parental cells, A375P-Hygro, and A375P-IL-10-positive cells were injected s.c. and i.v. into nude mice. A375P-IL-10 cells produced significantly slower growing s.c. tumors and fewer lung metastases than control cells. The tumorigenicity of the human melanoma A375SM and the murine melanoma B16-BL6 cells was also significantly inhibited when they were admixed with A375P-IL-10 but not with A375P-Hygro before s. c. injection into nude mice. The suppression of tumor growth and metastasis was directly correlated with a decrease in neovascularity determined by immunostaining with anti-factor VIII. Because tumor-associated macrophages are the major source of angiogenic molecules in melanoma, we used reverse transcription-PCR to demonstrate that IL-10 down-regulates the production of vascular endothelial growth factor, the most potent angiogenic factor in activated macrophages. Other factors involved in angiogenesis such as IL-1beta, tumor necrosis factor-alpha, IL-6, and the proteinase matrix metalloproteinase-9 were also inhibited in activated macrophages by supernatants from A375P-IL-10 cells. Collectively, these data suggest that the production of IL-10 by tumor cells inhibits macrophages-derived angiogenic factors, and hence, tumor growth and metastasis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Carcinogenicity Tests
  • Collagenases / biosynthesis
  • Down-Regulation
  • Endothelial Growth Factors / metabolism
  • Humans
  • Interleukin-1 / biosynthesis
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / genetics
  • Interleukin-10 / therapeutic use*
  • Interleukin-6 / biosynthesis
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology
  • Lung Neoplasms / prevention & control
  • Lung Neoplasms / secondary
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphokines / metabolism
  • Macrophages / enzymology
  • Macrophages / metabolism
  • Male
  • Matrix Metalloproteinase 9
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Melanoma / secondary
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Transplantation
  • Neovascularization, Pathologic / prevention & control
  • Transfection
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Antineoplastic Agents
  • Endothelial Growth Factors
  • Interleukin-1
  • Interleukin-6
  • Lymphokines
  • Tumor Necrosis Factor-alpha
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Interleukin-10
  • Collagenases
  • Matrix Metalloproteinase 9